Company Filing History:
1 out of 832,843 Years Active: 1998
Title: The Innovations of Tomas Porstmann
Introduction
Tomas Porstmann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. His work focuses on addressing critical health challenges, such as the human immunodeficiency virus (HIV).
Latest Patents
Tomas Porstmann holds a patent for "Human monoclonal anti-HIV-I-antibodies." This invention is directed to human monoclonal antibodies that are specific for the gp41 envelope protein of HIV-1. The patent specifically discloses human monoclonal antibodies produced by the cell lines 3D6, 24G3, and 25C2, each with their respective ECACC Accession Numbers.
Career Highlights
Throughout his career, Tomas Porstmann has demonstrated a commitment to advancing medical science through innovative research. His patent reflects his dedication to developing therapeutic solutions for HIV, a virus that continues to impact millions worldwide.
Collaborations
Tomas has collaborated with esteemed colleagues in his field, including Hermann W Katinger and Ruediger Von Baehr. These partnerships have likely enhanced the quality and impact of his research.
Conclusion
Tomas Porstmann's contributions to the field of biotechnology, particularly through his patent on human monoclonal antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in HIV treatment and research.